Animal models of nicotine withdrawal: Intracranial self-stimulation and somatic signs of withdrawal

Methods in Molecular Biology

Volumn 829, Issue , 2012, Pages 257-268

  Bauzo, Rayna M ^a   Bruijnzeel, Adrie W ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Intracranial self stimulation; Nicotine; Somatic signs; Withdrawal

Indexed keywords

NICOTINE;

ADDICTION; ANIMAL; ANIMAL BEHAVIOR; ANIMAL MODEL; ARTICLE; BRAIN DEPTH STIMULATION; DRUG SELF ADMINISTRATION; MALE; METHODOLOGY; RAT; SMOKING; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

ANIMALS; BEHAVIOR, ANIMAL; DEEP BRAIN STIMULATION; MALE; MODELS, ANIMAL; NICOTINE; RATS; SELF ADMINISTRATION; SMOKING; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; TOBACCO USE DISORDER;

ANIMALIA; NICOTIANA TABACUM;

EID: 84856350580     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-458-2_16     Document Type: Article

References (26)

1. Markou, A.; Koob, G.; (Eds.) (1993) Intracranial self-stimulation thresholds as a measure of reward, Vol. 2, Oxford University Press, New York.
2. Koob, G.; Markou, A.; Weiss, F.; Schulteis, G. (1993) Opponent process and drug dependence: Neurobiological mechanisms, Semin Neurosci 5, 351-358. (Pubitemid 23322891)
3. Volkow, N. (2009) Tobacco Addiction, in Research Report, National Institute on Drug Abuse, Rockville, MD.
4. (2009) Results from the 2008 National Survey on Drug Use and Health: National Findings Substance Abuse and Mental Health Services Administration, Rockville, MD.
5. Le Foll, B.; Goldberg, S. R. (2009) Effects of nicotine in experimental animals and humans: an update on addictive properties, Handb Exp Pharmacol, 335-367.
6. Benowitz, N. L. (2009) Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics, Annu Rev Pharmacol Toxicol 49, 57-71.
7. Anthony, J. C.; Warner, L. A.; Kessler, R. C. (1994) Comparative Epidemiology of Dependence on Tobacco, Alcohol, Controlled Substances, and Inhalants: Basic Findings From the National Comorbidity Survey, Experimental and Clinical Psychopharmacology 2, 244-268.
8. Caggiula, A. R.; Donny, E. C.; White, A. R.; Chaudhri, N.; Booth, S.; Gharib, M. A.; Hoffman, A.; Perkins, K. A.; Sved, A. F. (2001) Cue dependency of nicotine selfadministration and smoking, Pharmacol Biochem Behav 70, 515-530. (Pubitemid 34131646)
9. Hughes, J. R.; Gust, S. W.; Skoog, K.; Keenan, R. M.; Fenwick, J. W. (1991) Symptoms of tobacco withdrawal. A replication and extension, Arch Gen Psychiatry 48, 52-59.
10. Hughes, J. R.; Hatsukami, D. (1986) Signs and symptoms of tobacco withdrawal, Arch Gen Psychiatry 43, 289-294. (Pubitemid 16052281)
11. Hughes, J. R. (2006) Clinical signifi cance of tobacco withdrawal, Nicotine Tob Res 8, 153-156. (Pubitemid 43675071)
12. Wesnes, K.; Warburton, D. M. (1983) Smoking, nicotine and human performance, Pharmacol Ther 21, 189-208. (Pubitemid 13045802)
13. Bruijnzeel, A. W.; Gold, M. S. (2005) The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence, Brain Res Brain Res Rev 49, 505-528. (Pubitemid 41546656)
14. Koob, G. F. (2008) A role for brain stress systems in addiction, Neuron 59, 11-34. (Pubitemid 351905857)
15. Epping-Jordan, M. P.; Watkins, S. S.; Koob, G. F.; Markou, A. (1998) Dramatic decreases in brain reward function during nicotine withdrawal, Nature 393, 76-79. (Pubitemid 28240257)
16. Malin, D. H.; Lake, J. R.; Carter, V. A.; Cunningham, J. S.; Hebert, K. M.; Conrad, D. L.; Wilson, O. B. (1994) The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat, Psychopharmacology (Berl) 115, 180-184. (Pubitemid 24207780)
17. Malin, D. H.; Lake, J. R.; Newlin-Maultsby, P.; Roberts, L. K.; Lanier, J. G.; Carter, V. A.; Cunningham, J. S.; Wilson, O. B. (1992) Rodent model of nicotine abstinence syndrome, Pharmacol Biochem Behav 43, 779-784.
18. Hildebrand, B. E.; Nomikos, G. G.; Bondjers, C.; Nisell, M.; Svensson, T. H. (1997) Behavioral manifestations of the nicotine abstinence syndrome in the rat: peripheral versus central mechanisms, Psychopharmacology (Berl) 129, 348-356. (Pubitemid 27092998)
19. Paterson, N. E. (2009) The neuropharmacological substrates of nicotine reward: reinforcing versus reinforcement-enhancing effects of nicotine, Behav Pharmacol 20, 211-225.
20. Nakahara, D. (2004) Infl uence of nicotine on brain reward systems: study of intracranial selfstimulation, Ann NY Acad Sci 1025, 489-490. (Pubitemid 39643898)
21. Bespalov, A.; Lebedev, A.; Panchenko, G.; Zvartau, E. (1999) Effects of abused drugs on thresholds and breaking points of intracranial self-stimulationinrats, EurNeuropsychopharmacol 9, 377-383. (Pubitemid 29415717)
22. Markou, A.; Koob, G. F. (1991) Postcocaine anhedonia. An animal model of cocaine withdrawal, Neuropsychopharmacology 4, 17-26.
23. Lin, D.; Koob, G. F.; Markou, A. (1999) Differential effects of withdrawal from chronic amphetamine or fl uoxetine administration on brain stimulation reward in the rat - interactions between the two drugs, Psychopharmacology (Berl) 145, 283-294. (Pubitemid 29393478)
24. Schulteis, G.; Markou, A.; Gold, L. H.; Stinus, L.; Koob, G. F. (1994) Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative doseresponse analysis, J Pharmacol Exp Ther 271, 1391-1398. (Pubitemid 24382650)
25. Schulteis, G.; Markou, A.; Cole, M.; Koob, G. F. (1995) Decreased brain reward produced by ethanol withdrawal, Proc Natl Acad Sci USA 92, 5880-5884.
26. Leith, N. J.; Barrett, R. J. (1976) Amphetamine and the reward system: evidence for tolerance and post-drug depression, Psychopharmacologia 46, 19-25.